Current and Future Treatment Strategies for Patients with Advanced Hepatocellular Carcinoma: Role of mTOR Inhibition

Publisher： Karger

E-ISSN： 1664-5553|1|3-4|247-256

ISSN： 2235-1795

Source： Liver Cancer, Vol.1, Iss.3-4, 2012-11, pp. : 247-256

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

mTOR Inhibitor for the Treatment of Hepatocellular Carcinoma

By  

Digestive Diseases, Vol. 29, Iss. 3, 2011-08 ,pp. : 310-315

Karger

Access to resources Recommend Favorite

Molecular targeted therapy for advanced hepatocellular carcinoma: current status and future perspectives

By Shen Ying-Chun   Hsu Chiun   Cheng Ann-Lii  

Journal of Gastroenterology, Vol. 45, Iss. 8, 2010-08 ,pp. : 794-807

Springer Publishing Company

Access to resources Recommend Favorite

Multimodal Treatment Strategies in Patients Undergoing Surgery for Hepatocellular Carcinoma

By  

Digestive Diseases, Vol. 31, Iss. 1, 2013-06 ,pp. : 112-117

Karger

Access to resources Recommend Favorite

Future Treatment Option for Hepatocellular Carcinoma: A Focus on Brivanib

By  

Digestive Diseases, Vol. 29, Iss. 3, 2011-08 ,pp. : 316-320

Karger

Access to resources Recommend Favorite

Current Status of Liver Transplantation for Treatment of Hepatocellular Carcinoma

By  

Digestive Diseases, Vol. 19, Iss. 4, 2002-03 ,pp. : 333-337

Karger

Access to resources Recommend Favorite